Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: aknahow who wrote (10293)	5/31/1999 9:08:00 PM
From: Cacaito	Read Replies (3) \| Respond to of 17367

CAVEAT: THESE ARE NOT REAL RESULTS, ONLY A GUESS, P 0.05 Power 80% Two tail test Total recruitment = 395 Total deceased = 34 GROUP 1, Low mortality (low G score 8-11): 80% = 313 G1 placebo 156 patients, mortality 8% = 12 deceased G1 bpi 157 patients, mortality 1% = 2 deceased GROUP 2, High mortality (high G score 12 to 15) = 82 G2 placebo, 41 patients, mortality 40% = 16 deceased G2 placebo, 41 patients, mortality 11% = 4 deceased This numbers are all approximations to fit into the known numbers. Some percentages and end numbers are approximations for ease of presentation. Real and Actual numbers must only come from the company and expected by the end of the trial, 90 days after last recruited patient, which is not publicly known yet. CAVEAT: THESE ARE NOT REAL RESULTS. ONLY A GUESS. The poster owns Xoma shares. He rates Xoma shares a hold for high risk investors. Confirm numbers on your own. This is not an offer to buy, neither a solicitation to sell. For entertainment purposes only. All disclaimers apply.